Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1Breast 1

Conditions

Testicular Neoplasms 1Neoplasm Metastasis 1Lymphoma 1Breast Neoplasms 1

Interventions

Filgrastim 4Carboplatin 4Peripheral Blood Stem Cell Transplantation 3Magnetic Resonance Spectroscopy 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Busulfan 3aflibercept 2Trastuzumab 2Temozolomide 2Radiotherapy 2Polymerase Chain Reaction 2Melphalan 2Interleukin-12 Subunit p35 2Fluorodeoxyglucose F18 2Flow Cytometry 2FAPI-46 2Cyclophosphamide 2Bone Marrow Transplantation 2veliparib 1trioctyl phosphine oxide 1tipifarnib 1sodium thiosulfate 1sargramostim 1ixabepilone 1isophosphamide mustard 1guadecitabine 1fludarabine phosphate 1entinostat 1claudin 6 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Testicular Neoplasms × Interleukin-1 × Clear all
NCT00001270 2008-03-04

Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
85 enrolled
BreastGenitourinaryLymphoid

Breast Neoplasms, Lymphoma, Neoplasm Metastasis, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡